Literature DB >> 29731005

Molecular Aspects of Allergens and Allergy.

Rudolf Valenta1, Alexander Karaulov2, Verena Niederberger3, Pia Gattinger4, Marianne van Hage5, Sabine Flicker4, Birgit Linhart4, Raffaela Campana4, Margarete Focke-Tejkl4, Mirela Curin4, Julia Eckl-Dorna3, Christian Lupinek4, Yvonne Resch-Marat4, Susanne Vrtala4, Irene Mittermann4, Victoria Garib6, Musa Khaitov7, Peter Valent8, Winfried F Pickl9.   

Abstract

Immunoglobulin E (IgE)-associated allergy is the most common immune disorder. More than 30% of the population suffer from symptoms of allergy which are often severe, disabling, and life threatening such as asthma and anaphylaxis. Population-based birth cohort studies show that up to 60% of the world population exhibit IgE sensitization to allergens, of which most are protein antigens. Thirty years ago the first allergen-encoding cDNAs have been isolated. In the meantime, the structures of most of the allergens relevant for disease in humans have been solved. Here we provide an update regarding what has been learned through the use of defined allergen molecules (i.e., molecular allergology) and about mechanisms of allergic disease in humans. We focus on new insights gained regarding the process of sensitization to allergens, allergen-specific secondary immune responses, and mechanisms underlying allergic inflammation and discuss open questions. We then show how molecular forms of diagnosis and specific immunotherapy are currently revolutionizing diagnosis and treatment of allergic patients and how allergen-specific approaches may be used for the preventive eradication of allergy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergen; Allergy; Immunoglobulin E; Molecular allergology; Recombinant allergen

Mesh:

Substances:

Year:  2018        PMID: 29731005     DOI: 10.1016/bs.ai.2018.03.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  33 in total

Review 1.  From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack.

Authors:  Verena Fuhrmann; Huey-Jy Huang; Aysegul Akarsu; Igor Shilovskiy; Olga Elisyutina; Musa Khaitov; Marianne van Hage; Birgit Linhart; Margarete Focke-Tejkl; Rudolf Valenta; Bulent Enis Sekerel
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 2.  Recombinant allergens for immunotherapy: state of the art.

Authors:  Yury Zhernov; Mirela Curin; Musa Khaitov; Alexander Karaulov; Rudolf Valenta
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

Review 3.  Egg Allergy: Diagnosis and Immunotherapy.

Authors:  Dulashi Withanage Dona; Cenk Suphioglu
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

4.  Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules.

Authors:  Florin-Dan Popescu; Mariana Vieru
Journal:  World J Methodol       Date:  2018-11-29

Review 5.  Tracing IgE-Producing Cells in Allergic Patients.

Authors:  Julia Eckl-Dorna; Sergio Villazala-Merino; Nicholas James Campion; Maria Byazrova; Alexander Filatov; Dmitry Kudlay; Antonina Karsonova; Ksenja Riabova; Musa Khaitov; Alexander Karaulov; Verena Niederberger-Leppin; Rudolf Valenta
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

6.  IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational.

Authors:  Mirela Curin; Huey-Jy Huang; Tetiana Garmatiuk; Sandra Gutfreund; Yvonne Resch-Marat; Kuan-Wei Chen; Kerstin Fauland; Walter Keller; Petra Zieglmayer; René Zieglmayer; Patrick Lemell; Friedrich Horak; Wolfgang Hemmer; Margarete Focke-Tejkl; Sabine Flicker; Susanne Vrtala; Rudolf Valenta
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

Review 7.  Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?

Authors:  Inna Tulaeva; Bernhard Kratzer; Raffaela Campana; Mirela Curin; Marianne van Hage; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Musa Khaitov; Winfried F Pickl; Rudolf Valenta
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

8.  Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model.

Authors:  Bernhard Kratzer; Cordula Köhler; Sandra Hofer; Ursula Smole; Doris Trapin; Jagoba Iturri; Dietmar Pum; Philip Kienzl; Adelheid Elbe-Bürger; Pia Gattinger; Irene Mittermann; Birgit Linhart; Gabriele Gadermaier; Beatrice Jahn-Schmid; Alina Neunkirchner; Rudolf Valenta; Winfried F Pickl
Journal:  Allergy       Date:  2018-11-05       Impact factor: 13.146

Review 9.  Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?

Authors:  Rudolf Valenta; Alexander Karaulov; Verena Niederberger; Yury Zhernov; Olga Elisyutina; Raffaela Campana; Margarete Focke-Tejkl; Mirela Curin; Leyla Namazova-Baranova; Jiu-Yao Wang; Ruby Pawankar; Musa Khaitov
Journal:  J Allergy Clin Immunol Pract       Date:  2018-10-05

Review 10.  Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.

Authors:  Julia Eckl-Dorna; Sergio Villazala-Merino; Birgit Linhart; Alexander V Karaulov; Yury Zhernov; Musa Khaitov; Verena Niederberger-Leppin; Rudolf Valenta
Journal:  Front Immunol       Date:  2019-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.